Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma

Langenbeck's Archives of Surgery

Volumn 384, Issue 4, 1999, Pages 328-338

  Lorenz, Matthias ^a   Müller, Hans Helge ^b   Staib Sebler, Elsbeth ^a   Vetter, Gregor ^a   Gog, Christiane ^a   Petrowsky, Henrik ^a   Köhne, Claus Henning ^c  

^a GOETHE UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Adjuvant chemotherapy; Colorectal cancer; Liver metastases; Neoadjuvant chemotherapy

Indexed keywords

CARMOFUR; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; FLOXURIDINE; FLUOROURACIL; LEVAMISOLE; METHOTREXATE;

BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COLORECTAL CANCER; DIARRHEA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STOMATITIS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HUMANS; IMMUNOTHERAPY; LIVER NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL;

EID: 0345493751     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050210     Document Type: Review

References (80)

1. Ackerman NB, Lien WM, Kondi ES. Silvermann NA (1969) The blood supply of experimental liver metastases. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 66:1067-1072
2. Akasu T, Moriya Y, Takayama T (1997) A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolisation. Jpn J Clin Oncol 27:331-335
3. The Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10:896-903
4. Andersson R, Holmberg A (1992) Intraperitoneal 5-fluorouracil in the management of colorectal liver cancer. Eur J Surg Oncol 18:152-155
5. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76:545-548
6. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Philip PA-C, Schneider PD (1985) Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201:210-218
7. Balch CM, Urist MM, Soong S-J, McGregor M (1983) A prospective phase II clinical trial of continuous FUdR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198:567-573
8. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
9. Bignami P, Doci R, Montalto F, Fissi S, di Bartolomeo M, Gennari L (1995) Feasibility of intraportal chemotherapy with fluorouracil and folinic acid immediately after hepatic resection for colorectal metastases. Tumori 81:96-101
10. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, Majno P, Engerran L (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509-522
11. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685-693
12. Cunliffe WJ, Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early post-operative intraperitoneal chemotherapy. Br J Surg 76:1082-1090
13. Curley SA, Roh MS. Chase JL, Hohn DC (1993) Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166:743-746
14. de Gramont A, Figer A, Seymour M, Homerin M, le Bail N, Cassidy J, Boni C. Cortes-Funes H, Freyer G, Hendler D, Louvet C (1998) A randomized trial of leucoviorin (LV) and 5-fluorouracil (5FU) with or without oxaliplatin in advanced colorectal cancer (CRC) (abstract). Proc Am Soc Clin Oncol 17:985
15. Douglas HO Jr (1987) Adjuvant treatment in colorectal cancer: an update. World J Surg 11:478-492
16. Edmondson HA, Peters RL (1987) Neoplasms of the liver. In: Shiff L, Schiff EL (eds) Disease of the liver. Lippincott, Philadelphia, pp 1103-1158
17. Elias D, Lasser P, Rougier P, Nitenberg G. Théodore C, Lumbroso J (1987) Early adjuvant intraportal chemotherapy after curative hepatectomy for colorectal liver metastases - a pilot study. Eur J Surg Oncol 13:247-250
18. Elias D, Cavalcanti A, Sabourin JC, Lassau N, Pignon JP, Ducreux M, Coyle C, Lasser P (1998) Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 24:174-179
19. Ensminger WD, Gyves JW (1984) Regional cancer chemotherapy. Cancer Treat Rep 68:101-115
20. Erlichman C, Marsoni S, Seitz JF, Skillings J, Shepherd L, Zee B, Milan B. Bedenne L, Giovanni M, Pienkowski P, Torri V, Tardio B, Smerieri F, Pancera G, Martignoni G (1994) Event free and overall survival is increased by FU/FA in resected B and C colon cancer: a prospective pooled analysis of randomized trials (RCTS) (abstract). Proc Am Soc Clin Oncol 13:562
21. Finlay IG, McArdle CS (1986) Occult hepatic metastases in colorectal carcinoma. Br J Surg 73:732-735
22. Fisher ER, Turnbull PB (1955) The cytological demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal cancer. Surg Gynecol Obstet 100:102-107
23. Fischer B, Fischer E (1959) Experimental studies influencing hepatic metastases. Effect of partial hepatectomy. Cancer 12:929-932
24. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938-946
25. Fortner JG, Silva JS, Golbey RB, Cox EB, MacLean BJ (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Treatment by hepatic resection. Ann Surg 199:306-316
26. Graf W, Westlin JE, Pahlman L, Glimelius B (1994) Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study. Int J Colorect Dis 9:35-39
27. Herrmann G, Lorenz M, Kirkowa-Reimann M, et al. (1987) Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterol 3:5-9
28. Hodgson WJB, Friedland M, Ahmed T, Mittelman A, Berman H, Katz S, Morgan J, Byrne D (1986) Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203:420-425
29. Hohn DC, Rayner AA Ecconomou JS, Ignoffo RJ, Lewis BJ, Stagg RJ (1986) Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 57:465-470
30. Hughes K, Foster J, et al. (1991) The role of adjuvant chemotherapy following curative hepatic resection of colorectal metastases (abstract). Proc Am Soc Clin Oncol 10:145
31. Karpoff HM, D'Angelica M, Blair S, Brownlee MD, Federoff H, Fong Y (1997) Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest 99:799-804
32. Kemeny N, Cohen A, Huang Y, Shi W, Blumgart L, Turnbull A, Sullivan D, Stockman J, Fong Y (1999) Randomized study of hepatic arterial infusion (HAI) and systemic chemotherapy (SYS) versus SYS alone as adjuvant therapy after resection of hepatic metastases from colorectal cancer (Abstract)
33. Kemeny MM, Adak S, Lipsitz S, Gray B, MacDonald J, Benson III AB (1999) Results of the Intergroup [Eastern Cooperative Oncology Group (ECOG) and Southwest Oncology Group (SWOG)] Prospective randomized study of surgery alone versus continuous hepatic artery infusion of FUDR and continuous systemic infusion of 5FU after hepatic resection for colorectal liver metastases (Abstract) ASCO 1999
34. Köhne CH, Schoffski P, Wilke H, Kaufer C, Andreesen R, Ohl U, Klaasen U, Westerhausen M, Hiddemann W, Schott G, Harstick A, Bade J, Horster A, Schubert U, Hecker H, Dorken B, Schmoll HJ (1998) Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer. J Clin Oncol 16:418-26
35. Kokudo N, Seki M, Ohta H, Azekura K, Ueno M, Sato T, Moroguchi A, Matsubara T, Takahashi T, Nakajima T, Aiba K (1998) Effects of systemic and regional chemotherapy after hepatic resection for colorectal metastases. Ann Surg Oncol 5:706-712
36. Lorenz M, Staib-Sebler E, Koch B, Gog C, Waldeyer M, Encke A (1997) The value of postoperative hepatic arterial infusion following curative liver resection. Anticancer Res 17:3825-3833
37. Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K, Hauss J, Stieger R, Jauch KW, Bechstein W, Encke A (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorourcail and folinic acid for liver metastases of colorectal cancer. Ann Surg 228:756-762
38. Lygidakis NJ, Ziras N, Parissis J (1995) Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 42:155-161
39. Matheme H, Lovquist A, Graf W, Lundqvist H, Carlson I, Sundin A (1998) Adjuvante 1311-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases. Anticancer Res 18:843-848
40. Meta-Analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258
41. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358
42. Moriya Y, Sugihara KK, Hojo K, Mahuuchi M (1991) Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: a pilot study. European J Surg Oncol 17:519-525
43. Morrow CE, Grage TB, Sutherland DER (1982) Hepatic resection for secondary neoplasms. Surgery 92:610-610
44. Müller JM, Schmidt A, Strauss JM, Zieren HU (1991) Resektion von Lebermetastasen kolorektaler Karzinome. Anspruch und Wirklichkeit. Dtsch Med Wochenschr 116:681-688
45. Naniemo T, Takeichi N, Hata Y (1989) Analysis of mechanism of the effect of partial hepatectomy on enhanced growth of liver cancer in rats: experimental analysis of the mechanism of recurrences after liver surgery in human liver cancer. Acta Hepatol Jpn 30:889-897
46. Nitti D, Civalleri D, Samori G, Bachi V, Dapian P, Labianca R, Pancera G, Lise M, Panvini D, Tinazzi A, Torri V, Marsoni S (1994) Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Eur J Surg Oncol 20:454-460
47. Nonami T, Takeuchi Y, Yasui M, Kurokawa T, Taniguch K, Harada A, Nakao A, Takagi H (1997) Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Sem Oncol 242[suppl 6]:56130-56134
48. Nordlinger B, Bouteloup PY, Favre JP, Jaeck D, Pellissier E, Grandjean JP, Arnaud JP, Fourtanier G, Letoublan C, Marre P, Parc R (1990) Early post-operative intraperitoneal chemotherapy is feasible and well tolerated in colon cancer. A prospective randomized study. J Cancer Res Clin Oncol 116:686
49. Nordlinger B, Panis Y, Puts JP, Herve JP, Deleto R, Ballet F (1991) An experimental model of colon cancer: recurrences after surgery alone or associated with intraperitoneal 5-fluorouracil chemotherapy. Dis Colon Rect 34:658-663
50. Nordlinger B, Jaeck D, Guiguet M, Vaillant JC, Balladur P, Schaal JC (1992) Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery. In: Nordlinger B, Jaeck D (eds) Treatment of hepatic metastases of colorectal cancer, 1st edn. Springer, Berlin Heidelberg New York, pp 129-146
51. O'Connel MJ, Adson MA, Schutt AJ, Rubin J, Moertel CG, Ilstrup DM (1985) Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 60:517-520
52. Okuno K, Yasutomi M, Hida J, Kayama H, Nakai T, Funai S, Koh K (1998) Longterm effects of hepatic arterial interleukin-2- based immunotherapy after potentially curative resection of colorectal liver metastases. J Am Coll Surg 187:271-275
53. Panis Y, Ribeiro J, Chretien Y (1992) Dormant liver metastases: an experimental study. Br J Surg 79:221-223
54. Pardoll DM (1998) Cancer vaccines. Nat Med 4:525-531
55. Patt YZ, McBride CM, Ames FC, Claghorn LJ, Cleary KB, Boddie AW, Charnsangavej C, Mavligit CM (1987) Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867-873
56. PDQ in the World Wide Web: http://cancernet.nci.nih.gov/prot/protsrch.shtml
57. Picardo A, Karpoff HM, Ng B, Lee J, Brennan ME, Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124:57-64
58. Porte H, De Moulins H, Gambiez L, Wurtz A, Quandalle P (1995) A pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases. Surg Oncol 4:317-322
59. Raab R (1992) Adjuvante Behandlung nach Leberresekuon mit dem monoklonalen Antikörper 17-1 A. Lecture Symposium "Regionale Tumortherapie: Leber - Extremitäten - Peritoneum" in Frankfurt am Main
60. Rajpal S, Dasmahapatra KS, Ledesma EJ, Mittelmann A (1982) Extensive resection of isolated metastasis from carcinoma of the colon and rectum. Surg Gynecol Obstet 155:813-816
61. Riesener KP, Winkeltau G, Kasperk R, Cheng L, Schumpelick V (1998) Adjuvant regional chemotherapy following resection of colorectal hepatic metastases. Chirurg 69:741-764
62. Riethmüller G, Holz E, Schlimok G, Schiegel W, Raab R, et al. (1998) Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 16:1788-1794
63. Rougier P, Laplanche A, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet J-C, Gallot D, Gouzi JL, Paillier JL, Elias D, Lacaine F, Roos S, Rotman N, Luboinski M, Lasser P (1992) Hepatic arterial infusion of floxururidine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 10:112-118
64. Schalhorn A, Kuhl M (1995) Pharmacology of regional chemotherapy of colorectal liver metastases. Zentralbl Chir 120:764-768
65. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surg 110:13-29
66. Scheele J, Stang P, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19:59-71
67. Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, Burger D, Stoger F, Ritschel J, Kovats E, Vischer HM, Schneeweiss B, Depisch D (1998) Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 77:1349-1354
68. Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, Liebrich W, Schirrmacher V (1992) Active specific immunotherapy with NDV modified autologous tumor cells following liver metastases resection in colorectal cancer. Cancer Immunol Immunoth 35:325-330
69. Speyer JL, Collins JM, Dedrick RL (1980) Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 40:567-572
70. Staib-Sebler E, Müller HH, Mattes P, Junginger T, Saeger HD, Lorenz M (1998) Multicenter trial of continuous 24 h hepatic arterial infusion of high-dose 5-FU and folinic acid for colorectal liver metastasis tumors. Langenbecks Arch Chir Suppl Kongreßbd 2:1441-1444
71. Staveley-O'Carroll K, Sotomayor E, Montgomery J, Borrello I, Hwang L, Fein S, Pardoll D, Levitsky H (1998) Induction of antigen-specific T cell anergy: an early event in the course of tumor progression. Proc Natl Acad Sci USA 95:1178-1183
72. Steele G Jr. Osteen RT, Wilson RE, Brooks DC, Mayer RJ, Zamcheck N, Ravikumar TS (1984) Patterns of failure after surgical cure of large liver tumors. A change in the proximate cause of death and a need for effective systemic adjuvant therapy. Am J Surg 147:554-559
73. Toda M, Rabkin SD, Martuza RL (1998) Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1. Hum Gene Ther 9:2177-2185
74. Tsujitani S, Watanabe A, Kakeji Y, Machara Y, Tomada H, Furusawa M, Sugimachi K (1991) Hepatic recurrence not prevented with low dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. Eur J Surg Oncol 17:526-529
75. Van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca P, Germa-Lluch JR, Morant R, Wils J, Rougier P, Dembak M, Cote C (1998) A phase III multicenter randomized trial comparing CPT-11 to infusional 5FU regimen in patients (Pts) with advanced colorectal cancer (ACRC) after 5FU failure (abstract). Proc Am Soc Clin Oncol 17:984
76. Vennook AP, Frye JW, Stagg RJ, Warren RS (1994) Adjuvant (ADJ) hepatic intra-arterial (HIA) chemotherapy (CTX) in patients with liver metastases (mets) from colorectal cancer (CRC) (abstract). Proc Am Soc Clin Oncol 13:657
77. Venook AP, Bergsland EK, Ring E, Nonaka-Wong S, Horowitz J A, Rybak ME, Warren RS (1998) Gene therapy of colorectal liver metastases using a recombinant adenovirus encoding WT p53 (SCH 58500) via hepatic artery infusion: a phase I study. Proc Am Soc Clin Oncol 17:431a
78. Vermorken IB, Claessen, Gall H, et al. (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353:345-350
79. Wagman JS, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU (1990) A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885-1893
80. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C (1996) Patient selection for hepatic resection of colorectal metastases. Arch Surg 131:322-329